FULL STACK DIGITAL CELL
Dead / Abandoned — Abandoned — no statement of use filed (as of 13 Oct 2026)
What this means for you
This application is over — abandoned 13 Oct 2026. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97388377
- Mark type
- Slogan / phrase
- Filed
- 29 Apr 2022
- Published for opposition
- 18 Jul 2023
- Abandoned
- 13 Oct 2026
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical compositions in the nature of chemical small molecules for treatment of cancer, autoimmune disorders, transplant rejections, inflammatory disease, immunological disorders, metabolic disorders, neurological disorders, genetic disorders, psychiatric disorders, gastroenterological disorders, renal disorders, cardiovascular disorders, dermatological disorders, respiratory disorders
- Class 009 — Scientific and electric apparatus: Recorded and downloadable software featuring machine learning and artificial intelligence for drug analysis in drug discovery and development; recorded and downloadable software incorporating artificial intelligence and machine learning models for collecting, analyzing, assessing, interpreting and predicting medical, health, transcriptional, genetic, genomic, pharmacogenomic, nutrigenomic, microbiomic, metabolomic, proteomic, biochemistry, and biomarker information, associations, conditions, outcomes, effects and risks
- Class 042 — Scientific and technological services: Bioinformatic services for scientific research purposes, namely, collecting and analyzing complex biological data through the use of artificial intelligence; computer assisted molecule design involving the use of artificial intelligence technology; cellular computer modeling, for scientific research purposes, for analyzing complex biological data through the use of artificial intelligence; providing online non-downloadable software featuring machine learning and artificial intelligence for drug analysis in drug discovery and development; scientific research, namely, research and analysis services in the scientific fields of artificial intelligence and machine learning analytics, healthcare, biomedical and genomic research; providing online non-downloadable software incorporating artificial intelligence and machine learning models for collecting, analyzing, assessing, interpreting and predicting medical, health, transcriptional, genetic, genomic, pharmacogenomic, nutrigenomic, microbiomic, metabolomic, proteomic, biochemistry, and biomarker information, associations, conditions, outcomes, effects and risks
Owner
- Cellarity, Inc., Somerville, MA, US
- Cellarity, Inc., Somerville, MA, US
Prosecution history
- 13 Oct 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 13 Oct 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 22 Jul 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Jul 2026 — SOU EXTENSION 5 GRANTED
- 10 Mar 2026 — SOU EXTENSION 5 FILED
- 21 Jul 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 11 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 12 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Sept 2025 — SOU EXTENSION 4 GRANTED
- 11 Sept 2025 — SOU EXTENSION 4 FILED
- 11 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 12 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Mar 2025 — SOU EXTENSION 3 GRANTED
- 11 Mar 2025 — SOU EXTENSION 3 FILED
- 11 Mar 2025 — SOU TEAS EXTENSION RECEIVED